ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Making The Lives Of Patients And Research Sites Easier

  Most clinical trials overlook one crucial factor: giving sites and patients a voice in how studies are run. That’s starting to change—and the impact is significant.

• Everest Group Life Sciences EDC Products PEAK Matrix^® Assessment 2024

  This Everest Group report examines Medidata’s Rave EDC and its impact on the clinical development value chain of life sciences.

• How Wearable Devices Improve Patient Engagement In Clinical Trials

  Wearables are no longer optional—they are foundational to the future of patient-centric, data-driven clinical research.

• Strong eCOA Provider And Linguistic Validation Expert Partner For Success

  Explore the creation and implementation of the electronic versions of COAs (eCOAs) on a high priority study with a new client.

• The Significance Of Quality Data In Meeting FDA Regulatory Scrutiny

  Data Science expert Rod McGlashing explains how scrutiny from the FDA spurs regulatory compliance, resulting in better data quality and the creation of optimal applications for intellectual property.

• The Strategic Case For RTSM in Phase 1 Trials

  Phase 1 trials demand precision and speed. RTSM delivers real-time control over enrollment, dosing, and supply, reducing risk and enabling adaptive strategies that keep timelines on track.

• A Beginner's Guide To Compliant Electronic Source Data Capture

  With today’s complex trials, the expectation of gathering faster results in an increasingly decentralized environment is only increasing, imploring investigators to implement electronic source data capture systems. How can researchers ensure this is done correctly? Leveraging the right technology to standardize a compliant process for source data capture is a proven way to reach these goals.

• Paperless Online Remote Source Document Verification

  Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.

• Why Oncology Drug Development Lags In Digital Biomarkers

  Despite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.

• Sustainable Clinical Trials Through eClinical Innovation

  Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.